NCT06081569View on ClinicalTrials.gov

Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

October 15, 2024

Study Completion Date

October 15, 2026

Conditions

Alzheimer DiseaseMild Cognitive Impairment

Interventions

DIAGNOSTIC_TEST

gait video; speech video; facial expression video;

The videos of participants' gait, facial expression, and speech will be recorded and analyzed further. Other routine diagnostic tests will also be performed such as imaging of MRI, cognitive scales, etc.

All Listed Sponsors

lead

First Hospital of China Medical University

OTHER

NCT06081569 - Multimodal Deep Learning for the Diagnosis and Assessment of Alzheimer's Disease | Biotech Hunter | Biotech Hunter